Dr. Harris Lari, Principal Investigator at Headlands Research – Canada – Metro Vancouver, will attend the Canadian Psychiatric Association (CPA) Annual Conference in Montreal, November 18–21.
Dr. Lari is a board-certified psychiatrist with more than 20 years of experience in academic medicine and clinical research. He has worked on early- and late-phase psychiatry trials with a focus on Alzheimer’s disease and neuropsychiatric disorders. That work includes Phase 1b/2a and Phase 2 randomized, double-blind, placebo-controlled studies of novel therapies for Alzheimer’s disease and cerebral amyloid angiopathy. He is also experienced in Health Canada’s Division 5 requirements for clinical trials.
Planning your Alzheimer’s or neuropsychiatry study? Schedule a meeting with Dr. Lari during the conference to learn how the Headlands network can support your research.